Business context and reporting period
Important filing-identity mismatch: The request identifies Red Cat Holdings, Inc., but the supplied Form 10-K is for Broadleaf Capital Partners, Inc. It reports the fiscal year ended December 31, 2013, with 2012 comparatives; it is not a quarterly report. The figures below summarize the supplied filing, not Red Cat.
Broadleaf described itself as a restructuring and investment company seeking cash-flow-positive acquisitions and other business opportunities. It sold Pipeline Nutrition U.S.A. Inc. to a related party on December 30, 2013, and retained Sustained Release, Inc., formed in November 2013. The private placement for Sustained Release raised no funds during the year.
Financial results and position
| Metric | FY 2013 | FY 2012 |
|---|---|---|
| Revenue | $8,467 | $633 |
| Operating expenses | $36,543 | $130,836 |
| Operating loss | $(28,076) | $(130,203) |
| Net income | $158,394 | $924,209 |
| Cash at year-end | $7,045 | $94,642 |
| Total assets | $307,045 | $219,642 |
| Total liabilities | $27,701 | $98,692 |
| Stockholders’ equity | $279,344 | $120,950 |
- 2013 net income included a $139,050 gain on the Pipeline sale, $46,871 of debt-forgiveness income, and $10,000 of interest income. Revenue was not sufficient to cover operating expenses; operating margins were negative.
- G&A and operating expenses fell by $94,293, mainly because Pipeline start-up costs and investment due-diligence fees incurred in 2012 did not recur.
- Net income fell $765,815 year over year, primarily reflecting the smaller investment-sale gain and lower debt-forgiveness income compared with 2012.
- The cash-flow statement reports $105,036 of cash provided by operating activities, no investing cash flow, and $192,633 of cash used in financing activities, resulting in an $87,597 decrease in cash. The financing amount includes $175,000 issued as a note receivable.
- Current liabilities were $27,701, including $12,750 of current notes payable; the filing reports no long-term debt. The balance sheet includes $300,000 of notes receivable, largely related to the Pipeline sale.
- Basic and diluted earnings per share were reported as $0.001 for 2013 and $0.006 for 2012. No cash dividends have been paid, and none were expected in the foreseeable future.
Outlook, risks, and unusual items
- The auditor’s report and management’s disclosures raise substantial doubt about Broadleaf’s ability to continue as a going concern. The company had an accumulated deficit of $14,029,261 and only $7,045 in cash at year-end.
- Management said it expected to fund current operations from remaining cash while pursuing joint ventures and acquisitions, and stated it did not expect to seek dilutive financing immediately. The filing provides no quantified guidance and gives no assurance that financing, profitable acquisitions, or operating profitability will be achieved.
- Broadleaf said it may raise capital through equity or debt, which could be unavailable on acceptable terms or materially dilute shareholders. Its common stock was thinly traded, subject to substantial price volatility, and characterized as a penny stock.
- The Pipeline sale was a related-party transaction. The filing describes a $325,000 amount owed after an initial payment in one section, while the balance sheet and note disclosures show $300,000 in notes receivable and describe staged payments. The CFO reportedly guaranteed Pipeline’s obligations; future royalties were also contingent on note repayment.
- Management concluded disclosure controls were effective, but internal control over financial reporting was not effective and a material weakness existed, citing limited staff and resources. The company had no audit committee, no audit committee financial expert, and no directors deemed independent.
- The filing reports no pending legal proceedings or reportable commitments and contingencies. It states there were no subsequent events.
- Unusual reporting inconsistency: the MD&A gives 2013 net income as $195,921 in one passage, while the audited statements report $158,394. The latter matches the statement of operations and equity roll-forward; the filing text does not clearly reconcile the difference.
Important facts for investors to verify
- Confirm the filing belongs to the intended issuer: the supplied document is Broadleaf Capital Partners, Inc., not Red Cat Holdings, Inc.
- Reconcile the $195,921 MD&A figure with audited 2013 net income of $158,394.
- Confirm the Pipeline sale’s related-party terms, the receivable balance and repayment schedule, the reported $325,000 versus $300,000 amounts, the guarantee, and the royalty arrangement.
- Assess collectability and timing of the $300,000 notes receivable relative to year-end cash of $7,045 and the going-concern warning.
- Review the material weakness in financial reporting controls and the absence of an audit committee and independent directors.